Free Alerts   Login
Health Care › Biological Products (No Diagnostic Substances)

IBRX Stock Price Correlated With ImmunityBio Financials

IBRX Stock Price vs. Quarterly
IBRX
Income Statement
Cash Flow
Balance Sheet

IBRX Income Statement

Enable JavaScript and reload
Revenue, Net:
Revenue Per Share:
Cost of Goods & Services Sold:
Gross Profit:
Selling, General & Admin Expense:
Research & Development Expense:
Total Operating Expenses:
Operating Income:
Income Taxes:
Net Income:
Earnings Per Share, Diluted:
Earnings Per Share, Basic:
Shares Outstanding, Basic Avg:
Shares Outstanding, Diluted Avg:
Common Stock Shares Outstanding:

IBRX Cash Flow

Enable JavaScript and reload
Operating Activities Net Income:
Depreciation, Depletion & Amortization:
Change in Accounts Receiveable:
Net Cash from Operations:
Net Cash from Operations Per Share:
Repurchases/Buybacks Common Stock:
Issuance of Long-term Debt:
Cash Dividends Paid:
Net Cash from Financing Activities:
Property, Plant & Equipment Purchases:
Purchases of Businesses, Net of Cash:
Net Cash from Investing Activities:
Net Change in Cash & Equivalents:

IBRX Balance Sheet

Enable JavaScript and reload
Cash and Cash Equivalents:
Short-Term Investments:
Accounts Receivable, Net:
Inventories:
Total Current Assets:
Property, Plant & Equipment, Net:
Total Assets:
Accounts Payable:
Current Portion of Long-Term Debt:
Total Short-Term Liabilities:
Long Term Debt, Non-Current Portion:
Total Long-Term Liabilities:
Total Liabilities:

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Vanguard Group
13,328,525 sh
-1,347,162 sh
-9%
$66,909
$42,107
Blackrock.
10,710,179 sh
-100,852 sh
-1%
$53,765
$35,496
State Street
9,470,909 sh
6,751,317 sh
248%
$47,544
$42,948
Geode Capital Management
3,379,464 sh
573,281 sh
20%
$16,967
$12,224
Credit Suisse Ag
1,529,908 sh
-4,229 sh
0%
$7,680
$5,088
JPMorgan Chase
1,422,212 sh
-26,220 sh
-2%
$7,139
$4,691
Northernrp
1,357,059 sh
204,302 sh
18%
$6,812
$4,863
Goldman Sachs Group
1,278,638 sh
850,874 sh
199%
$6,419
$5,696
Charles Schwab Investment Management
1,142,925 sh
92,991 sh
9%
$5,737
$3,963
Bank Of America /De/
891,815 sh
702,978 sh
372%
$4,476
$4,157
Jane Street Group
821,643 sh
674,911 sh
460%
$4,124
$3,716
Rafferty Asset Management
739,808 sh
739,808 sh
NEW
$3,714
$3,714
Allen Holding /Ny
687,571 sh
 
$3,452
Invesco.
641,363 sh
595,890 sh
1310%
$3,220
$3,143
Morgan Stanley
599,718 sh
201,817 sh
51%
$3,010
$2,336
D. E. Shaw & Co..
591,101 sh
591,101 sh
NEW
$2,967
$2,967
Putnam Investments
534,201 sh
534,201 sh
NEW
$2,682
$2,682
Nuveen Asset Management
522,477 sh
45,198 sh
9%
$2,623
$1,816
Bank Of New York Mellon
482,435 sh
-35,792 sh
-7%
$2,422
$1,546
Barclays Plc
479,545 sh
435,172 sh
981%
$2

Free historical financial statements for ImmunityBio Inc.. See how revenue, income, cash flow, and balance sheet financials have changed over 32 quarters since 2016. Compare with IBRX stock chart to see long term trends.

Data imported from ImmunityBio Inc. SEC filings. Check original filings before making any investment decision.